(Q36470237)

14 August 2017

title

Radical prostatectomy as primary treatment modality for locally advanced prostate cancer: a prospective analysis (English)

1 reference

14 August 2017

1 reference

6

Jihad Kaouk

1 reference

14 August 2017

5

Inderbir Gill

1 reference

14 August 2017

3

James C Ulchaker

1 reference

14 August 2017

1

Ryan K Berglund

1 reference

14 August 2017

4

Amr Fergany

1 reference

14 August 2017

J Stephen Jones

2

1 reference

14 August 2017

Eric A Klein

series ordinal

7

1 reference

14 August 2017

language of work or name

English

0 references

publication date

6 May 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

67

1 reference

14 August 2017

issue

6

1 reference

14 August 2017

page(s)

1253-1256

1 reference

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.003

Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.003

Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.003

Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.003

Radical radiation for localized prostate cancer: local persistence of disease results in a late wave of metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.003

Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.003

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.003

Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.003

Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.003

Phase II trial of neoadjuvant docetaxel before radical prostatectomy for locally advanced prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.003

Neoadjuvant docetaxel and estramustine chemotherapy in high-risk/locally advanced prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.003

10.1016/J.UROLOGY.2005.12.003

7 January 2021

Identifiers

DOI

1 reference

14 August 2017

1 reference